Staging and response to therapy of malignant pleural mesothelioma

Lung Cancer

Volumn 45, Issue SUPPL., 2004, Pages

  Heelan, Robert ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Computed tomography (CT); IMIG staging system; Magnetic resonance imaging (MRI); Malignant pleural mesothelioma; PET scanning; RECIST criteria

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; MALIGNANT MESOTHELIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

HUMANS; INTERNATIONAL COOPERATION; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 3142671923     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.04.013     Document Type: Conference Paper

References (14)

1. Butchart E.G., Ashcroft T., Barnsley W.C., Holden M.P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 31:1976;15-24
2. Mattson K. Natural history and clinical staging of malignant mesothelioma (abstract). Eur J Respir Dis 1982;(Suppl):63-87.
3. Rusch VW, Ginsberg RJ. New concepts in the staging of mesotheliomas. In: Deslauriers J, Lacquet LK, editors. Thoracic surgery: surgical management of pleural diseases. St. Louis: Mosby, 1990. pp. 336-43.
4. Boutin C., Rey F., Gouvernet J., Viallat J.R., Astoul P., Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. II. Prognosis and staging. Cancer. 72:1993;394-404
5. Dimitrov NV, McMahon S. Presentation, diagnostic methods, staging, and natural history of malignant mesothelioma. In: Antman K, Asiner J, editors. Asbestos-related malignancy. Orlando, FL: Grune & Stratton, 1987. pp. 225-38.
6. Tammilehto L., Kivisaari L., Salminen U.S., Maasilta P., Mattson K. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients. Lung Cancer. 12:1995;25-34
7. Patz E.F. Jr., Shaffer K., Piwnica-Worms D.R., Jochelson M., Sarin M., Sugarbaker D.J., et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. Am. J. Roentgenol. 159:1992;961-966
8. Rusch VW, editor. The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122-28.
9. Patz E.F. Jr., Rusch V.W., Heelan R. The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging. Am. J. Roentgenol. 66:1996;323-327
10. Sugarbaker D.J., Strauss G.M., Lynch T.J., Richards W., Mentzer S.J., Lee T.H., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J. Clin. Oncol. 11:1993;172-178
11. Heelan R.T., Rusch V.W., Begg C.B., Panicek D.M., Caravelli J.F., Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. Am. J. Roentgenol. 172:1999;1039-1047
12. Rusch V.W., Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 111:1996;815-826
13. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214
14. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 92:2000;205-216